On-Demand DCT Webinars

81. Hindsight Is So 2020: Getting Ahead Of CNS Trial Enrollment In A Rapidly Changing Clinical Landscape 12/11/2020

    The past six months have highlighted both existing and unexpected enrollment challenges, as sponsors, CROs, and sites have been pressed to evolve their recruitment strategies. Join the webinar to hear experts discuss their approach to adapting CNS trial enrollment to a rapidly changing clinical landscape.

82. Decentralized Clinical Trials In Action: Blending Clinical Payments Technology And eCOA For Study Success 12/1/2020

    When the catalyst of the COVID-19 pandemic wanes, we risk losing the progress our industry has made unless we collectively refuse to go back to the way things were before - and instead dedicate ourselves to implementing even more advancements and innovations that we've only dreamed of.   

83. Speed vs Safety: How Regulators Are Sizing Up Evidence Today 11/19/2020

    In drug development, there is always pressure to move quickly, and with today’s push to develop treatments and vaccines for COVID, those pressures are exacerbated. In this webinar, the speakers will ground their predictions for the future in the historic response of regulatory bodies to epidemics, then explore recent shifts in the regulatory environment in response to COVID and the resulting new efficiencies in drug development.

84. Mitigating Covid-19 Through A Hybrid Decentralized Clinical Trials Approach 10/15/2020

    The covid-19 pandemic has presented the industry with many risks and challenges to the management of clinical trials. In this webinar, we will discuss what risks and challenges COVID-19 has presented, ways in which these can be addressed.

85. CROs: The Tip Of The Spear In Maximizing The Value of Hybrid, Virtual, And Synthetic Clinical Trials 9/2/2020

    Hybrid, virtual, and synthetic clinical trials are becoming a part of an increasing number of drug and biologics development programs. In this webinar, Rho experts discuss how their approach to maximizing the benefits of decentralized trials helps sponsors get the most out of their trials through offering solutions that bridge the gap across an ever-increasing number of data collection systems, leverage the information real-time, and bring this information to bear on business decisions, clinical trial execution decisions, and marketing application dossiers.

86. Virtual Study Designs 5/14/2019

    Virtual study designs are transforming the way biopharmaceutical businesses conduct research. Tactics that decentralize the approach to clinical and observational research are ushering in a new paradigm of efficient data collection and patient centric engagement.

87. Optimizing Your Direct-To-Patient Clinical Trial Logistics Webinar 3/27/2019

    Patient enrollment and retention remain a critical variable in clinical trial studies. Increasingly, sponsors are looking to the DTP trial model for certain patient populations, such as the elderly and critically ill. Watch this on-demand webinar and learn how to optimize your distribution chain for direct-to-patient clinical trials.

88. Harness The Power Of eCOA In Your Next Trial

    In this webinar, explore the importance of eCOAs, how they have evolved from the standard paper diaries, and what efficiencies you can realize from them.

89. Applying Virtual Approaches To Dermatology Trials

    Explore how to integrate virtual approaches into the design and delivery of dermatology trials – to mitigate study risks and enhance patient engagement.

90. Smart Packaging In Clinical Trials: The Power Of Adherence Data

    Individual data points over time can provide precise drug dosing histories that enable better understanding of protocol adherence, safety, efficacy, PK/PD and a drug’s exposure-response relationship.